Xue Xia
- Biomaterials top 2%
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems 7
- Neurology top 5%
- Neuroinflammation and Neurodegeneration Mechanisms 8
- Molecular Medicine top 5%
-
- Advanced Glycation End Products research 10
-
- Bone Tissue Engineering Materials 10
- Graphene and Nanomaterials Applications 7
-
- Protein Hydrolysis and Bioactive Peptides 7
-
- Biochemical Analysis and Sensing Techniques 7
-
- Biochemical effects in animals 6
- Journals
- Journal of Agricultural and Food Chemistry (12 papers)Food Chemistry (6 papers)Acta Pharmaceutica Sinica B (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xue Xia
112 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 125
- Biomaterials 422
- Pharmaceutical Science 149
- Neurology 172
- Molecular Medicine 90
- Complementary and alternative medicine 148
Countries citing papers authored by Xue Xia
This map shows the geographic impact of Xue Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Xia more than expected).
Fields of papers citing papers by Xue Xia
This network shows the impact of papers produced by Xue Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Xia. The network helps show where Xue Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xue Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 16 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 4 | |
| 6 | Nanotechnology for enhanced nose-to-brain drug delivery in treating neurological diseasesbreakdown → | 2024 | 75 |
| 7 | 2024 | 2 | |
| 8 | 2024 | 4 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 16 | |
| 11 | 2021 | 217 | |
| 12 | 2021 | 19 | |
| 13 | 2021 | 22 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 38 | |
| 16 | 2021 | 15 | |
| 17 | 2019 | 61 | |
| 18 | 2016 | 9 | |
| 19 | Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions | 2014 | 5 |
| 20 | 2011 | 36 |
About Xue Xia
Xue Xia is a scholar working on Clinical Biochemistry, Neurology, Pharmaceutical Science, Biomaterials and Nutrition and Dietetics, having authored 116 papers that have together received 2.6k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (10 papers), Bone Tissue Engineering Materials (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers), Graphene and Nanomaterials Applications (7 papers), Advanced Drug Delivery Systems (7 papers), Protein Hydrolysis and Bioactive Peptides (7 papers), Biochemical Analysis and Sensing Techniques (7 papers) and Biochemical effects in animals (6 papers). The work is most often cited by research in Biomaterials (422 citations), Pharmaceutical Science (149 citations), Neurology (172 citations), Molecular Medicine (90 citations) and Complementary and alternative medicine (148 citations). Xue Xia has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Huile Gao, Yubao Li, Jidong Li, Yi Zuo, Shue Jin, Xian‐Jun Qu, Jinhui Huang, Deqing Sun, Xiaoming Zhang and Yuan Chen. Their work appears in journals such as Journal of Agricultural and Food Chemistry, Food Chemistry, Acta Pharmaceutica Sinica B, Journal of Controlled Release and Journal of Materials Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.